Herpes Simplex Completed Phase 3 Trials for Acyclovir (DB00787)
Also known as: Herpesviral infection, unspecified / Herpes simplex (disorder) / HSV infection / Herpesviral [herpes simplex] infections / Herpes simplex NOS
Indication | Status | Phase |
---|---|---|
DBCOND0027882 (Herpes Simplex) | Completed | 3 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT00031447 | Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth | Treatment | |
NCT00855309 | Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia | Supportive Care | |
NCT00000985 | Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir | Treatment | |
NCT00006135 | Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and Mouth | Treatment | |
NCT00000139 | Herpetic Eye Disease Study (HEDS) II | Treatment | |
NCT00004757 | Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and Mouth | Treatment | |
NCT00031460 | Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates | Treatment |